(Reuters) - U.S. regulators on Thursday approved the use of a drug made by Daiichi Sankyo Co Ltd to reduce the risk of stroke and blood clots in patients with an irregular heartbeat not caused by a heart valve problem.
via Reuters: Health News Read More Here..
No comments:
Post a Comment